-
1
-
-
0018659774
-
Heterosteroids and drug research
-
Ellis GP, West GB. Eds.; Springer: Amsterdam
-
Singh H, Kapoor VK, Paul D. Heterosteroids and drug research. In: Progress in Medicinal Chemistry, Vol. 16; Ellis GP, West GB. Eds.; Springer: Amsterdam, 1979; pp 35-150.
-
(1979)
Progress in Medicinal Chemistry
, vol.16
, pp. 35-150
-
-
Singh, H.1
Kapoor, V.K.2
Paul, D.3
-
2
-
-
0026361992
-
Heterosteroids and drug research
-
Ellis GP, West GB. Eds.; Elsevier science publishers: Amsterdam
-
Singh H, Jindal DP, Yadav MR, Kumar M. Heterosteroids and drug research. In Progress in Medicinal Chemistry, Vol. 28; Ellis GP, West GB. Eds.; Elsevier science publishers: Amsterdam, 1991; pp 233-300.
-
(1991)
Progress in Medicinal Chemistry
, vol.28
, pp. 233-300
-
-
Singh, H.1
Jindal, D.P.2
Yadav, M.R.3
Kumar, M.4
-
3
-
-
0035690056
-
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?
-
DOI 10.1023/A:1013180214359
-
Carlini P, Frassoldati A, Marco SD, Casali A, Ruggeri EM, Nardi M, Papaldo P, Fabi A, Paoloni F, Cognetti F. Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable? Ann Oncol 2001;12:1539-43. (Pubitemid 34065882)
-
(2001)
Annals of Oncology
, vol.12
, Issue.11
, pp. 1539-1543
-
-
Carlini, P.1
Frassoldati, A.2
Marco, S.D.3
Casali, A.4
Ruggeri, E.M.5
Nardi, M.6
Papaldo, P.7
Fabi, A.8
Paoloni, F.9
Cognetti, F.10
-
4
-
-
0037320432
-
2-methoxyestradiol, a promising anticancer agent
-
DOI 10.1592/phco.23.2.165.32088
-
Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003;23:165-72. (Pubitemid 36197457)
-
(2003)
Pharmacotherapy
, vol.23
, Issue.2
, pp. 165-172
-
-
Lakhani, N.J.1
Sarkar, M.A.2
Venitz, J.3
Figg, W.D.4
-
5
-
-
0035991756
-
Synthesis and structure - Activity relationships of neuromuscular blocking agents
-
Tuba Z, Maho S, Vizi ES. Synthesis and structure-activity relationships of neuromuscular blocking agents. Curr Med Chem 2002;9:1507-36. (Pubitemid 34846205)
-
(2002)
Current Medicinal Chemistry
, vol.9
, Issue.16
, pp. 1507-1536
-
-
Tuba, Z.1
Maho, S.2
Vizi, E.S.3
-
6
-
-
79956203988
-
Synthesis, characterization and biological evaluation of some 16-E-arylidene androstane derivatives as potential anticancer agents
-
Guo H, Wu H, Yang J, Xiao Y, Altenbach HJ, Qiu G, Hu H, Wu Z, Wu Z, He X, Zhou D, Hu X. Synthesis, characterization and biological evaluation of some 16-E-arylidene androstane derivatives as potential anticancer agents. Steroids 2011;76:709-23.
-
(2011)
Steroids
, vol.76
, pp. 709-723
-
-
Guo, H.1
Wu, H.2
Yang, J.3
Xiao, Y.4
Altenbach, H.J.5
Qiu, G.6
Hu, H.7
Wu, Z.8
Wu, Z.9
He, X.10
Zhou, D.11
Hu, X.12
-
7
-
-
0019784732
-
Synthesis of 16-bromoacetoxy androgens and 17-bromoacetylamino-4- androsten-3-one: Potential affinity labels of human placental aromatase
-
DOI 10.1016/0039-128X(81)90029-5
-
Numazawa M, Osawa Y. Synthesis of 16-bromoacetoxy androgens and 17- bromoacetylamino-4-androsten-3-one: potential affinity labels of human placental aromatase. Steroids 1981;38:149-59. (Pubitemid 12242867)
-
(1981)
Steroids
, vol.38
, Issue.2
, pp. 149-159
-
-
Numazawa, M.1
Osawa, Y.2
-
8
-
-
55549091381
-
Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy)- Benzylidene]androstene derivatives as potent cytotoxic agents
-
Bansal R, Guleria S. Synthesis of 16E-[3-methoxy-4-(2-aminoethoxy)- benzylidene]androstene derivatives as potent cytotoxic agents. Steroids 2008;73:1391-9.
-
(2008)
Steroids
, vol.73
, pp. 1391-1399
-
-
Bansal, R.1
Guleria, S.2
-
9
-
-
4644254277
-
Synthesis and cytotoxic studies of hydroximino derivatives of some 16E-arylidenosteroids
-
Chattopadhaya R, Jindal DP, Maninder M, Gupta R. Synthesis and cytotoxic studies of hydroximino derivatives of some 16E-arylidenosteroids. Arzneim Forsch/Drug Res 2004;54:551-6. (Pubitemid 39274017)
-
(2004)
Arzneimittel-Forschung/Drug Research
, vol.54
, Issue.9
, pp. 551-556
-
-
Chattopadhaya, R.1
Jindal, D.P.2
Minu, M.3
Gupta, R.4
-
10
-
-
79952427860
-
Synthesis and biological evaluation of 16E-arylidenosteroids as cytotoxic and anti-aromatase agents
-
Bansal R, Guleria S, Thota S, Hartmann RW, Zimmer C. Synthesis and biological evaluation of 16E-arylidenosteroids as cytotoxic and anti-aromatase agents. Chem Pharm Bull 2011;59:327-31.
-
(2011)
Chem Pharm Bull
, vol.59
, pp. 327-331
-
-
Bansal, R.1
Guleria, S.2
Thota, S.3
Hartmann, R.W.4
Zimmer, C.5
-
11
-
-
0032510321
-
Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17-alpha-hydroxylase-C-17,20-lyase (P450(17) alpha): Potent agents for the treatment of prostate cancer
-
Njar VC, Kato K, Nnane IP, Gringoryev DN, Long BJ, Brodie AM. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17-alpha-hydroxylase- C-17,20-lyase (P450(17) alpha): Potent agents for the treatment of prostate cancer. J Med Chem 1998;41:902-12.
-
(1998)
J Med Chem
, vol.41
, pp. 902-912
-
-
Njar, V.C.1
Kato, K.2
Nnane, I.P.3
Gringoryev, D.N.4
Long, B.J.5
Brodie, A.M.6
-
12
-
-
0023517368
-
In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A
-
Steele RE, Mellor LB, Sawyer WK, Wasvary JM, Browne LJ. In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A. Steroids 1987;50:147-61.
-
(1987)
Steroids
, vol.50
, pp. 147-161
-
-
Steele, R.E.1
Mellor, L.B.2
Sawyer, W.K.3
Wasvary, J.M.4
Browne, L.J.5
-
13
-
-
34248330459
-
Inhibitors of steroidal cytochrome P450 enzymes as targets for drug development
-
Baston E, Leroux FR. Inhibitors of steroidal cytochrome P450 enzymes as targets for drug development. Rec Patents Anti-Cancer Drug Dis 2007;2:31-58.
-
(2007)
Rec Patents Anti-Cancer Drug Dis
, vol.2
, pp. 31-58
-
-
Baston, E.1
Leroux, F.R.2
-
14
-
-
18844443185
-
Aromatase inhibitors in the treatment of breast cancer
-
DOI 10.1210/er.2004-0015
-
Brueggemeier RW, Hackett JC, Diaz-Cruz ES. Aromatase inhibitors in the treatment of breast cancer. Endocrine Rev 2005;26:331-45. (Pubitemid 40686647)
-
(2005)
Endocrine Reviews
, vol.26
, Issue.3
, pp. 331-345
-
-
Brueggemeier, R.W.1
Hackett, J.C.2
Diaz-Cruz, E.S.3
-
15
-
-
26444502089
-
Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: Design, synthesis, and biological activity evaluation
-
DOI 10.1021/jm050129p
-
Cepa MM, Tavares da Silva EJ, Correia-da-Silva G, Roleira FM, Teixeira AAA. Structure-activity relationships of new A, D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation. J Med Chem 2005;48:6379-85. (Pubitemid 41428989)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.20
, pp. 6379-6385
-
-
Cepa, M.M.D.S.1
Tavares, D.S.2
Correia-Da-Silva, G.3
Roleira, F.M.F.4
Teixeira, N.A.A.5
-
16
-
-
28544451936
-
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach
-
DOI 10.1021/jm058042r
-
Cavalli A, Bisi A, Bertucci C, Rosini C, Paluszcak A, Gobbi S, Giorgio E, Rampa A, Belluti F, Piazzi L, Valenti P, Hartmann RW, Recanatini M. Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach. J Med Chem 2005;48:7282-9. (Pubitemid 41743641)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.23
, pp. 7282-7289
-
-
Cavalli, A.1
Bisi, A.2
Bertucci, C.3
Rosini, C.4
Paluszcak, A.5
Gobbi, S.6
Giorgio, E.7
Rampa, A.8
Belluti, F.9
Piazzi, L.10
Valenti, P.11
Hartmann, R.W.12
Recanatini, M.13
-
17
-
-
0033535149
-
New selective nonsteroidal aromatase inhibitors: Synthesis and inhibitory activity of 2, 3 or 5-(α-azolylbenzyl)-1H-indoles
-
DOI 10.1016/S0960-894X(98)00737-9, PII S0960894X98007379
-
Le Borgne M, Marchand P, Delovoye-Seiller B, Robert JM, Robert-Piessard S, Le Baut G, Hartman RW, Palzer M. New selective nonsteroidal aromatase inhibitors: Synthesis and inhibitory activity of 2,3 or 5-(α-azolybenzyl)- 1Hindoles. Bioorg Med Chem Lett 1999;9:333-6. (Pubitemid 29084489)
-
(1999)
Bioorganic and Medicinal Chemistry Letters
, vol.9
, Issue.3
, pp. 333-336
-
-
Le, B.M.1
Marchand, P.2
Delevoye-Seiller, B.3
Robert, J.-M.4
Le, B.G.5
Hartmann, R.W.6
Palzer, M.7
-
18
-
-
0030006607
-
2
-
DOI 10.1002/ardp.19963290506
-
Hartmann RW, Frotscher M, Ledergerber D, Wächter GA, Grün GL, Sergejew TF. Synthesis and evaluation of azole-substituted tetrahydronaphthalenes as inhibitors of P450 arom, P450 17 and P450 TxA2. Arch Pharm 1996;329: 251-61. (Pubitemid 26186124)
-
(1996)
Archiv der Pharmazie
, vol.329
, Issue.5
, pp. 251-261
-
-
Hartmann, R.W.1
Frotscher, M.2
Ledergerber, D.3
Wachter, G.A.4
Grun, G.L.5
Sergejew, T.F.6
-
19
-
-
78751648440
-
Synthesis of quaternary ammonium salts of 16E-[4-(2-alkylaminoethoxy) methoxybenzylidene]androstene derivatives as skeletal muscle relaxants
-
Bansal R, Guleria S, Young LC, Harvey AL. Synthesis of quaternary ammonium salts of 16E-[4-(2-alkylaminoethoxy)methoxybenzylidene]androstene derivatives as skeletal muscle relaxants. Steroids 2011;76:254-60.
-
(2011)
Steroids
, vol.76
, pp. 254-260
-
-
Bansal, R.1
Guleria, S.2
Young, L.C.3
Harvey, A.L.4
-
20
-
-
0025295648
-
Neuromuscular and cardiovascular effects of pipecuronium
-
Foldes FF, Nagashima H, Nguyen HD, Duncalf D, Goldiner PL. Neuromuscular and cardiovascular effects of pipecuronium. Can J Anaesth 1990;37:549-55. (Pubitemid 20223338)
-
(1990)
Canadian Journal of Anaesthesia
, vol.37
, Issue.5
, pp. 549-555
-
-
Foldes, F.F.1
Hagashima, H.2
Nguyen, H.D.3
Duncalf, D.4
Goldiner, P.L.5
-
21
-
-
0024827665
-
Comparative potency of pipecuronium bromide and pancuronium bromide
-
Stanley JC, Mirakhur RK. Comparative potency of pipecuronium bromide and pancuronium bromide. Br J Anaesth 1989;63:754-5. (Pubitemid 20019107)
-
(1989)
British Journal of Anaesthesia
, vol.63
, Issue.6
, pp. 754-755
-
-
Stanley, J.C.1
Mirakhur, R.K.2
-
22
-
-
4644227875
-
Bromination of 17-oxo steroids with cupric bromide
-
Glazier ER. Bromination of 17-oxo steroids with cupric bromide. J Org Chem 1962;27:2937-8.
-
(1962)
J Org Chem
, vol.27
, pp. 2937-2938
-
-
Glazier, E.R.1
-
23
-
-
0026676380
-
The National Cancer Institute: Cancer drug discovery and development program
-
Grever MR, Schepartz SA, Chabner B. A. The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 1992;19:622-38. (Pubitemid 23004840)
-
(1992)
Seminars in Oncology
, vol.19
, Issue.6
, pp. 622-638
-
-
Grever, M.R.1
Schepartz, S.A.2
Chabner, B.A.3
-
24
-
-
0028906786
-
Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen
-
Boyd MR, Paull KD. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 1995;34:91-109.
-
(1995)
Drug Dev Res
, vol.34
, pp. 91-109
-
-
Boyd, M.R.1
Paull, K.D.2
-
25
-
-
0016293443
-
Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione
-
Thompson EA, Siiteri PK. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 1974;249:5364-72.
-
(1974)
J Biol Chem
, vol.249
, pp. 5364-5372
-
-
Thompson, E.A.1
Siiteri, P.K.2
-
26
-
-
0020561509
-
Analogues of aminoglutethimide: Selective inhibition of cholesterol side-chain cleavage
-
Foster AB, Jarman M, Leung S, Rowlands MG, Taylor GN. Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage. J Med Chem 1983;26:50-4. (Pubitemid 13092639)
-
(1983)
Journal of Medicinal Chemistry
, vol.26
, Issue.1
, pp. 50-54
-
-
Foster, A.B.1
Jarman, M.2
Leung, C.S.3
-
27
-
-
0018365924
-
Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide
-
Graves PE, Salhanick HA. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide. Endocrinology 1979;105:s52-57.
-
(1979)
Endocrinology
, vol.105
-
-
Graves, P.E.1
Salhanick, H.A.2
-
28
-
-
0022470925
-
Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones
-
Hartmann RW, Batzl C. Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl) piperidine-2,6-diones. J Med Chem 1986;29:1362-9. (Pubitemid 16034622)
-
(1986)
Journal of Medicinal Chemistry
, vol.29
, Issue.8
, pp. 1362-1369
-
-
Hartmann, R.W.1
Batzl, C.2
-
33
-
-
0000064019
-
Stereospecific synthesis of 16-hydroxy-17-oxo steroids by controlled alkaline hydrolysis of corresponding 16-bromo-17-ketones and its reaction mechanism
-
Numazawa M, Nagaoka M. Stereospecific synthesis of 16-hydroxy-17-oxo steroids by controlled alkaline hydrolysis of corresponding 16-bromo-17-ketones and its reaction mechanism. J Org Chem 1982;47:4024-9.
-
(1982)
J Org Chem
, vol.47
, pp. 4024-4029
-
-
Numazawa, M.1
Nagaoka, M.2
-
34
-
-
24344483855
-
Toward rapid, "green", predictable microwave-assisted synthesis
-
DOI 10.1021/ar040278m
-
Roberts BA, Strauss CR. Toward rapid, "green", predictable microwave-assisted synthesis. Acc Chem Res 2005;38:653-61. (Pubitemid 41260519)
-
(2005)
Accounts of Chemical Research
, vol.38
, Issue.8
, pp. 653-661
-
-
Roberts, B.A.1
Strauss, C.R.2
-
35
-
-
77949664753
-
New bisquaternary isoquinolinium inhibitors of brain cholinesterases - Synthesis and anticholinesterase activity
-
Binder J, Paar M, Jun D, Pohanka M, Hrabinova M, Opletalova V, Kuca K. New bisquaternary isoquinolinium inhibitors of brain cholinesterases - Synthesis and anticholinesterase activity. Lett Drug Des Dis 2010;7:1-4.
-
(2010)
Lett Drug des Dis
, vol.7
, pp. 1-4
-
-
Binder, J.1
Paar, M.2
Jun, D.3
Pohanka, M.4
Hrabinova, M.5
Opletalova, V.6
Kuca, K.7
|